Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

JAMA. 2005 Oct 26;294(16):2043-51.

PMID:
16249418
3.

[Bacteremic pneumococcal pneumonia].

Pineda Solas V, Pérez Benito A, Domingo Puiggros M, Larramona Carrera H, Segura Porta F, Fontanals Aymerich D.

An Esp Pediatr. 2002 Nov;57(5):408-13. Spanish.

PMID:
12467543
4.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

5.

The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.

Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ.

J Infect Dis. 1994 Aug;170(2):368-76.

PMID:
8035023
6.

Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.

Tan TQ.

Clin Microbiol Rev. 2012 Jul;25(3):409-19. doi: 10.1128/CMR.00018-12. Review.

7.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
8.

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A.

JAMA. 2007 Apr 25;297(16):1784-92.

PMID:
17456820
9.

Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.

Nzenze SA, Madhi SA, Shiri T, Klugman KP, de Gouveia L, Moore DP, Karstaedt AS, Tempia S, Nunes MC, von Gottberg A.

Am J Epidemiol. 2017 Aug 15;186(4):435-444. doi: 10.1093/aje/kwx048.

PMID:
28482004
10.

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.

11.

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, Patton M, McDonough A, Moradoghli-Haftvani A, Smith H, Mellelieu T, Pride MW, Crowther G, Schmoele-Thoma B, Scott DA, Jansen KU, Lobatto R, Oosterman B, Visser N, Caspers E, Smorenburg A, Emini EA, Gruber WC, Grobbee DE.

N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.

12.

Pneumococcal Vaccination in Adults.

Sherpa TY, Leaf HL.

Curr Infect Dis Rep. 2005 May;7(3):211-217.

PMID:
15847724
13.

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.

Bricks LF, Berezin E.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S67-74. Epub 2006 May 19. Review.

14.

A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.

Chalmers JD, Campling J, Dicker A, Woodhead M, Madhava H.

BMC Pulm Med. 2016 May 11;16(1):77. doi: 10.1186/s12890-016-0242-0. Review.

15.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

16.

[Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].

de Arístegui Fernández J, Corretger Rauet JM, García Martín F, Hernández-Sampelayo T, Moraga Llop FA, Rodrigo Gonzalo De Liria C, Ruiz Contreras J; Comité Asesor deVacunas de la Asociación Española de Pediatría.

An Esp Pediatr. 2002 Jan;56(1):79-90. Review. Spanish.

PMID:
11792258
17.

Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.

Yildirim I, Stevenson A, Hsu KK, Pelton SI.

Pediatr Infect Dis J. 2012 Oct;31(10):1016-21. doi: 10.1097/INF.0b013e3182615615.

PMID:
22673142
18.
19.

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine.

Aristegui J, Bernaola E, Pocheville I, García C, Arranz L, Durán G, Pérez L, Bastida M, Canduela C, Herranz Aguirre M, Garrote E, Fletcher MA, Pérez C.

Eur J Clin Microbiol Infect Dis. 2007 May;26(5):303-10.

PMID:
17457623
20.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400

Supplemental Content

Support Center